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Anxiety and depression in the elderly individuals have been studied around the world, 
and some authors consider them among the most serious problems faced by modern 
societies. With recent economic crisis—very important in Southern European countries—
isolation, loneliness, and exclusion of the active society, mental problems are probably 
raising and associated with distinct factors. In this cross-sectional analysis, nested in a 
longitudinal population-based cohort study, we analyze anxiety and depression prev-
alence, and their related factors, in a representative cohort of Portuguese seniors. We 
used data retrieved from second wave of follow-up of EpiDoC Cohort—EpiDoC 2 study, 
which is composed by 10,661 adults, representative of adult Portuguese population. 
This study included all ≥65 years old EpiDoC 2 study participants, who responded to 
Hospital Anxiety and Depression Scale (HADS), n = 1,680. Sociodemographic, lifestyles, 
self-reported non-communicable diseases, health-related quality of life (EQ-5D-3D), 
physical function (HAQ), and health resources consumption data were collected. Anxiety 
and depression were assessed with HADS. Anxiety and depression prevalence were 
estimated. Multivariable logistic regression was used to assess anxiety and depression 
score determinants. The estimated prevalence of anxiety among Portuguese elderly is 
9.6% and depression is 11.8%. Seniors with anxiety and seniors with depression have 
a higher probability to self-report higher levels of physical disability (OR = 3.10; 96% CI 
2.12–4.52; OR = 3.08, 95% CI 2.29–4.14, respectively) and lower levels of quality of life 
(OR = 0.03, 95% CI 0.01–0.09; OR = 0.03, 95% CI 0.01–0.06, respectively). Female 
gender (OR =  2.77, 95% CI 1.53–5.00), low educational level (OR =  2.30, 95% CI 
1.22–4.36), allergic (OR = 2.02, 95% CI 1.14–3.55), and rheumatic disease (OR = 2.92, 
95% CI 1.74–4.90) were significantly and independently associated with the presence of 
anxiety symptoms. Physical inactivity (OR = 1.64, 95% CI 1.11–2.42) and low educational 
level (OR = 2.40, 95% CI 1.41–4.09) were significantly and independently associated 
with depression symptoms. Subjects that reported to drink alcohol daily or occasionally 
were negatively associated with depression symptoms. Anxiety and depression are 
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frequent among Portuguese elderly. These prevalence rates suggest that preventing 
mental illness in senior population is a crucial need. A well-designed prevention strategy 
might have an effective action in raising the well-being of elderly.
Keywords: older, anxiety, depression, non-communicable chronic diseases, lifestyles, quality of life, function
inTrODUcTiOn
Our world is now old and aging. Aging population is a long-term 
trend in Portugal, Europe, and around the World. According to 
United Nations data from 2015, the number of people over 65 has 
increased considerably in the largest regions of the world, and 
this aging is expected to accelerate in the coming decades (1). 
The same data point out that, in 2015, 1 in 8 people in the world 
were 60 years or older, totaling 901 million elderly people. A 176 
million of these elderly people live in Europe.
In Portugal, the number of people over 65 years of age doubled 
in relation to the 1970s and, by 2015, was already over two mil-
lion, with the population over 80 years old increasing fivefold. 
In concrete terms, there were 836,058 people aged 65 and over 
in Portugal in 1971. In 1977, they surpassed one million and, in 
2012, two million. In 2015, they were 2,122,996 (2).
Although the epidemiological investigation has begun to 
converge regarding the estimation of the prevalence of anxiety 
and depression in elderly populations, there are still quite a few 
discrepancies (3). The sampling procedures diverge greatly: some 
studies use representative samples from the respective country, 
and others use samples of convenience. In addition, there is con-
siderable instability in age cutoffs considered for the definition 
of the elderly or older adult. On the other hand, there is much 
variation in the operationalization of anxiety and depression, 
partly due to the use of different evaluation instruments. In fact, 
some authors consider that anxiety and depression are among the 
most serious problems faced by modern societies is depression 
among the elderly (4). Although depression is fairly common in 
the last years of life (5), there is great variation in its prevalence 
in studies worldwide (9–33%) (6).
Factors associated with aging, such as social isolation, reduced 
autonomy, financial insecurity, and poor health, cause an increase 
in the prevalence of these disorders (7).
Some studies point to psychosocial risk factors for anxiety 
disorders and late-onset depression: female gender, cognitive 
dysfunction, chronic illness, poor health perception, functional 
limitations, personality traits such as neuroticism and weak cop-
ing strategies (8, 9). Specifically, for anxiety disorder: not having 
children, low income, and experiencing traumatic events (10).
Given the social and economic context of our country, 
generating relevant evidence on anxiety and depressive symp-
toms in the Portuguese elderly population, and understanding 
them from a point of view that goes beyond the mental ill-
ness itself, by approaching the possible associated factors, is 
crucial. Data on elderly mental health and associated factors 
could be useful to address therapeutic programs and better 
planning of health care.
Therefore, to comprehend models of anxiety and depression 
independently in the Portuguese senior population, this study 
aims to: (1) determine the prevalence of anxiety and depression 
symptoms and (2) identify relevant associations between the 
symptoms of anxiety and depression and chronic self-reported 
non-communicable diseases, lifestyles, and sociodemographic 
characteristics.
MaTerials anD MeThODs
sample
To analyze the older adult Portuguese population in terms of 
symptoms of anxiety and depression, their association with 
non-communicable chronic diseases, function, lifestyles, and 
quality of life we used data from the second wave of follow-up 
for EpiDoC Cohort—EpiDoC 2 (CoReumaPt) study—done by 
computer-assisted telephone interviews (CATIs).
The EpiDoC 2 evaluation consisted on a structured ques-
tionnaire, applied through phone call interviews to 10,153 
eligible participants of EpiDoC 1 (EpiReumaPt) (11–13), a large 
population-based sample, who consented to be contacted again 
for follow-up. The study population comprised adults (≥18 years 
old) living in the community, in Portugal Mainland and Islands 
(Azores and Madeira). Exclusion criteria were as follows: 
being resident in institutions and individuals unable to speak 
Portuguese or to complete the assessment protocol. Participants 
were selected through a process of multistage random sampling. 
The sample was stratified by region and population size.
EpiDoC 2 (CoReumaPt) included 7,591 participants, repre-
sentative of the adult Portuguese population. This study included 
1,680 seniors (65 and more years old) of the EpiDoC 2 study, who 
responded to Hospital Anxiety and Depression Scale (HADS) 
(Figure 1).
Data collection
Data collection was performed from March 26th 2013 to July 27th 
2015. A trained research assistants’ team was responsible for col-
lecting the follow-up data from these subjects, by randomly call 
all the individuals. When a contact was not available, they would 
hold more attempts in different moments (morning, afternoon, 
evening, and weekends) to perform six attempts. The last contact 
had to have at least 1 month of interval from the previous one. 
Only then the contact would be abandoned. Rescheduling of the 
telephonic interviews to a more convenient moment was also 
an option. The interview was telephonically performed with the 
assistance of a CATI system.
Data were collected in a standardized form, and database 
access was protected by unique username and password, for each 
research team member, according to Portuguese Law of data col-
lection (14).
FigUre 1 | Flowchart describing population eligible for this study.
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Measurements, assessment,  
and instruments
Case Definition
To evaluate symptoms of anxiety and depression in EpiDoC 2 
study, the HADS Portuguese validated version was applied (15). 
The HADS was originally developed by Zigmond and Snaith 
(16) as a screening tool to apprehend clinically significant states 
of anxiety and depression in a non-psychiatric hospital setting. 
Individual anxiety and depression scores were calculated by 
summation of the appropriate seven items and thus can range 
from 0 to 21, with higher scores indicating higher levels of anxiety 
or depression, respectively. In both subscales, a score between 0 
and 7 is “normal,” between 8 and 10 “mild,” between 11 and 14 
“moderate,” and between 15 and 21 “severe” (idem). Presence of 
anxiety and depression symptoms was defined when HADS scale 
was ≥11, since Snaith suggested a score ≥11 was indicative of 
“caseness” to a mood disorder (17). We also used the HADS scale 
as a continuous outcome in the final analyses.
Sociodemographic and Socioeconomic 
Characteristics
Information on sociodemographic (sex, age, years of education, 
household composition, and NUT II), as well as socioeco-
nomic variables (household income), was collected in the first 
wave—EpiDoC 1 study. Subjects were asked in the EpiDoC 2 
study interview whether there have been changes.
Health Characteristics
In EpiDoC 1 study, individuals were asked if they had been pre-
viously diagnosed with some chronic disease (high cholesterol 
level, high blood pressure, rheumatic disease, allergy, gastroin-
testinal disease, cardiac disease, diabetes, thyroid and parathyroid 
disease, urolithiasis, pulmonary disease, hyperuricemia, cancer, 
neurologic disease, and hypogonadism), and this information 
was updated in the EpiDoC 2 study interview.
Self-reported height and weight were collected in EpiDoC 
2. Based on these data, body mass index (BMI, weight/height2, 
in kg/m2) was calculated and categorized according to the World 
Health Organization classification in four categories: underweight 
(BMI <  18.5  kg/m2), normal (BMI between 18.5 and 24.9  kg/
m2), overweight (BMI between 25 and 29.9 kg/m2), and obesity 
(BMI ≥ 30 kg/m2) (18).
Health-related quality of life was assessed using the Portuguese 
validated version of European Quality of Life questionnaire 
(EQ-5D-3L) (19, 20).
Function was evaluated based on the Portuguese version of 
Health Assessment Questionnaire (HAQ) (21, 22).
To assess health-care resources consumption, “number 
of medical appointments in the previous 12  months” and 
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“hospitalization in the previous 12 months (yes/no)” was asked 
to participants.
Lifestyle Characteristics
In EpiDoC 2 study, questions concerning lifestyle habits included 
frequency of alcohol intake (daily, occasionally, and never), smok-
ing habits (current smoker, past smoker, and never smoked), 
sleep habits (number of hours of sleep per day, categorized in 
<6 and ≥6 h/day). Physical activity level was classified based on 
the question related to the reported weekly frequency of physical 
activity. A frequency of once a week or more was considered “yes” 
to regular physical exercise.
statistical analysis
Sample Weights
EpiDoC was designed to obtain a representative sample of the 
Portuguese population (13). To guarantee its representativeness, 
weighted proportions have, for this matter, been computed and 
are described elsewhere (13).
To maintain the representativeness of the sample in relation to 
the Portuguese population (Mainland and Islands) in the second 
wave, extrapolation weights were again computed and used in 
further statistical analysis. These were obtained by calibrating the 
extrapolation weights originally designed for the EpiDoC 1 study 
sample. We first compared the participants and non-participants 
of EpiDoC 2 study, concerning their sociodemographic, socio-
economic and rheumatic disease screening, and health status 
characteristics. Then, we decided to adjust weights based on the 
stratification by seven NUTII regions [Norte, Centro, Lisboa, 
Alentejo, Algarve, and islands (Azores and Madeira)], gender 
(male and female), age categories (18–35, 36–55, 56–65, ≥8–35, 
36–55 years old for NUTII Norte, Centro, and Lisboa; 18–65, 66+ 
for NUTII Alentejo, Algarve, and islands), and rheumatic disease 
screening (positive/negative).
analysis and statistical software
Descriptive data for each categorical variable were presented as the 
absolute frequency and the correspondent proportion, weighted. 
The same adjustment has been done for the mean and SD for each 
continuous variable. Continuous variables were compared using 
Student’s t-test or ANOVA, and nominal variables were compared 
using chi-square test.
To assess the determinants of anxiety and depression symp-
toms, we first performed univariate analysis to approach relations 
between independent variables (non-communicable chronic 
diseases, lifestyles, and sociodemographic characteristics) and 
outcomes (presence of anxiety and depression symptoms). When 
univariate analyses resulted in p-value  <  0.1, those variables 
were included into the multivariable logistic regression models. 
Multivariable models were constructed using a forward selection 
method. The following independent variables were tested: age, 
gender, NUTS II, education level (0–4 vs ≥5 years), BMI (under-
weight, normal, overweight, and obese), alcohol intake (never, daily, 
and occasionally), current smoking, physical activity (yes/no), 
and chronic non-communicable diseases—high blood pressure, 
diabetes, high cholesterol level, pulmonary disease, cardiac 
disease, neurologic disease, allergies, neoplasic disease, thyroid 
disease, hyperuricemia, and rheumatic disease. Age, gender, and 
NUTS II were forced to stay in the model. The goodness of fit of 
the final multivariable regression model for the outcome anxiety 
has p = 0.287, and the goodness of fit of the final multivariable 
regression model for the outcome depression has p = 0.4.
Significance level was set at 0.05. All analyses were weighted 
and executed using STATA IC version 12 (StataCorp. 2011. 
Stata Statistical Software: Release 12. College Station, TX, USA: 
StataCorp LP).
ethical issues and Data Protection
EpiDoC 1 study was performed following the principles estab-
lished by the Declaration of Helsinki (23) and revised in 2013 in 
Fortaleza. The study was reviewed and approved by the National 
Committee for Data Protection (Comissão Nacional de Proteção 
de Dados) and by the NOVA Medical School Ethics Committee. 
The participants provided informed consent to contribute in all 
phases of the study.
The EpiDoC 2 study was also approved by National Committee 
for Data Protection (in accordance with the Portuguese law num-
ber 67/98, October 26th, regarding protection of personal data) 
and was submitted to the same Ethics Committee. The study was 
conducted in accordance with the applicable laws and regulations 
including, but not limited to, the Guideline for Good Clinical 
Practice and the ethical principles stated in the Declaration of 
Helsinki (23).
Participants’ confidentiality is safeguarded by the nonexist-
ence of identifiers on the database (only unique ID participants’ 
codes). Their names and contacts are stored separately from study 
data transmitted to the coordinating center. Thus, all data are kept 
anonymously and securely by the EpiDoC 2 study authorized 
staff. During EpiDoC 1 study, informed consent was also signed 
by those accepting to participate in the EpiDoC 2 study. There 
will be absolutely no disclosure of individual health information 
to the general public.
resUlTs
Our population of interest included 1,680 participants over 
64 years old, 908 (54%) of those were females. Forty four percent 
were 75  years old or more. With respect to educational level, 
almost two-thirds of participants (n = 1,259; 76.03%) had less or 
equal to 4 years of education.
Most people with 65 years of age and more reported to live on a 
household income of less than 1,000€ per month; 35.8% reported 
the lowest income level of 500€/month. Moreover, elderlies tend 
to live in households are composed by only one (25.53%) or two 
persons (55.89%).
With respect to health-related characteristics, the observed 
mean number of non-communicable chronic diseases was 3.10 
(±2.1). The most frequently reported chronic diseases were high 
blood pressure (57.3%), rheumatic diseases (50.53%), and high 
cholesterol level (49.7%).
People 65+ years old score EQ-5D-3L on average 0.61 (±0.77) 
for quality of life and 0.72 (±0.72) in HAQ for physical function.
Table 1 | Prevalence of anxiety and depression in the Portuguese senior 
population by age group.
elderly with anxiety symptoms 
(haDs-a ≥11)
elderly with depression 
symptoms (haDs-D ≥11)
n (%) n (%)
Total 176 (9.59) 241 (11.77)
age group
65–69 y.o. 52 (12.38) 44 (7.29)
70–74 y.o. 45 (7.86) 65 (11.33)
75–79 y.o. 47 (8.99) 68 (15.16)
80–84 y.o. 20 (7.96) 42 (14.85)
≥85 y.o. 12 (9.56) 22 (1.68)
%, weighted percentage; HADS-A, Hospital Anxiety and Depression Scale—Anxiety 
subscale; HADS-D, Hospital Anxiety and Depression Scale-Depression subscale; y.o., 
year old.
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The high consumption of health care resources by the older 
age group matches the health status. The average number of 
appointments was 7.74 (±8.40), and 24.16% was hospitalized in 
the last 12 months.
Regarding lifestyle habits, namely, in terms of alcohol intake 
and smoking habits, 36.43% of the individuals had reported a daily 
intake of alcohol beverages but only 5.39% were current smokers. 
Among the elderly, 43.65% of the subjects never consume alcohol 
and 66.35% of people aged 65 and above never smoked. Almost 
60% of individuals above 65 years old do not engage in regular 
physical exercise, and around 70% of the Portuguese elderly sleep 
6 or more hours per day.
Prevalence of anxiety and  
Depression symptoms in the elderly
This study found 176 elderly out of 1,680 (10.48%) presenting 
anxiety symptoms (HADS-A ≥11), corresponding to a preva-
lence of 9.59% when weighted to Portuguese elderly population 
(Table 1). The mean score for HADS-A was 5.04 (±3.74).
In terms of depression symptoms, figures rise to 241 (14.34% 
in the present sample), equivalent to a prevalence of 11.77% of 
the Portuguese elderly population (Table 1). This population had 
a mean score for HADS-D of 5.27 (±4.07).
Sociodemographic, socioeconomic, lifestyle, and health-
related characteristics of the Portuguese elderly population with 
and without anxiety symptoms are summarized in Table 2.
Table 3 summarizes sociodemographic, socioeconomic, life-
style, and health-related seven characteristics of the Portuguese 
elderly population with and without depression symptoms.
anxiety and Depression symptoms  
and Physical Function in seniors
Seniors with anxiety have a higher probability to have reported, 
even after the adjustment for sex, age, region, and number of 
non-communicable diseases, higher levels of physical disability 
(OR = 3.10; 96% CI 2.12–4.52).
Similar results were found for depression symptoms and 
seniors with depression have reported higher levels of physical 
disability (OR = 3.08, 95% CI 2.29–4.14).
anxiety and Depression symptoms  
and Quality of life in the elderly
In terms of quality of life (EQ-5D-3L score), seniors with anxi-
ety have a higher probability to report lower levels of quality of 
life (OR =  0.03, 95% CI 0.01–0.09). These results were found 
after the adjustment for sex, age, region, and number of non-
communicable diseases.
Multivariable analyses adjusting to sex, age, region, and 
number of non-communicable diseases also showed that 
seniors with depression symptoms have a higher probability to 
have reported lower levels of quality of life (OR = 0.03; 95% CI 
0.01–0.06).
anxiety and Depression symptoms and 
health-care resources consumption in 
the elderly
Logistic regression adjusted to sex, age, region, and number of 
non-communicable diseases stressed that seniors with anxiety 
symptoms have a higher probability to have reported higher 
number of hospitalizations in the previous 12 months (OR = 2.53, 
95% CI 1.37–4.67) and have reported a higher number of medical 
appointments in the previous 12 months.
Seniors with depression symptoms have also a higher prob-
ability to have reported higher number of hospitalizations in the 
previous 12 months (OR = 1.55, 95% CI 1.01–2.35). In terms of 
number of medical appointments in the previous 12  months, 
there is no significant difference between elderly with and with-
out depressive symptoms.
sociodemographic, lifestyles, and  
health Factors independently associated 
with anxiety in seniors
Multivariable logistic regression, including all previous significant 
independent variables, showed that being a woman (OR = 2.77, 
95% CI 1.53–5.00) and have a low educational level (OR = 2.30, 
95% CI 1.22–4.36) were significantly associated with anxiety 
symptoms. Regarding self-reported non-communicable chronic 
diseases, our results showed that only allergies (OR  =  2.02, 
95% CI 1.14–3.55) and rheumatic disease (OR = 2.92, 95% CI 
1.74–4.90) were statistically significant associated with anxiety 
symptoms (Table 4).
sociodemographic, lifestyles, and  
health Factors independently associated 
with Depression in seniors
All previous significant independent variables were included in a 
multivariable logistic regression to depression symptoms. In this 
analysis, low educational level (OR = 2.40, 95% CI 1.41–4.09), 
physical inactivity (OR = 1.64, 95% CI 1.11–2.42), and alcohol 
intake on a daily (OR = 0.54, 95% CI 0.35–0.83) and occasionally 
basis (OR = 0.49, 95% CI 0.29–0.84) were protectors of depres-
sion (were associated with low risk of depression symptoms) 
(Table 5).
Table 2 | Sociodemographic, socioeconomic, lifestyle, and health-related characteristics of the Portuguese elderly population with and without anxiety symptoms.
sociodemographic and socioeconomic 
characteristics
elderly without anxiety  
symptoms (haDs-a <11)
elderly with anxiety  
symptoms (haDs-a ≥11)
p-Value adjusted 
p-value
Mean (sD) or n (%) Mean (sD) or n (%)
n = 1,504 (90.41%) n = 176 (9.59%)
age* (years) 74.24 (6.60) 73.96 (6.91) 0.059 0.131
Sex* Female 768 (83.85) 140 (15.15) <0.001† <0.001†
Male 736 (95.44) 36 (4.56)
NUTS II* Norte 476 (89.88) 67 (10.12) 0.906 0.977
Centro 378 (89.93) 49 (10.07)
Lisboa e Vale do Tejo 291 (90.56) 23 (9.44)
Alentejo 95 (92.11) 11 (7.89)
Algarve 57 (93.14) 3 (6.86)
Região Autónoma dos Açores 80 (93.04) 7 (6.96)
Região Autónoma da Madeira 127 (91.03) 16 (8.97)
Education level* ≤4 years of education 1,103 (88.55) 156 (11.45) 0.001† 0.002†
>4 years of education 377 (95.98) 20 (4.02)
Household income* (€) ≤500 384 (89.15) 58 (10.85) 0.430 0.411
501–750 301 (91.75) 31 (8.25)
751–1,000 152 (88.38) 16 (11.62)
>1,000 275 (94.52) 16 (5.48)
Household composition 1 374 (88.89) 55 (11.11) 0.388 0.900
≥2 1,130 (90.90) 121 (9.10)
anthropometric data*
BMI Underweight 9 (84.23) 2 (15.77) 0.806 0.723
Normal 397 (91.5) 47 (8.5)
Overweight 647 (90.2) 59 (9.8)
Obese 297 (91.32) 40 (8.68)
lifestyle characteristics
Alcohol intake* Never 630 (86.3) 102 (13.7) 0.002† 0.054
Daily intake 571 (94.7) 40 (5.5)
Occasionally 300 (90.6) 34 (9.4)
Smoke* Never 969 (89.5) 145 (10.5) 0.480 0.344
Past 449 (91.2) 25 (8.8)
Present 85 (95.5) 6 (4.5)
No regular physical exercise* 873 (91.0) 109 (9.0) 0.590 0.482
Sleep habits (h) <6 250 (87.7) 38 (12.3) <0.001† 0.003†
≥6 586 (95.9) 31 (4.1)
Quality of life and physical function**
EQ5D (0–1) 0.66 ± 0.01 0.31 ± 0.02 <0.001† <0.001†
HAQ score (0–3) 0.63 ± 0.03 1.4 ± 0.06 <0.001† <0.001†
Number of non-communicable diseases* 2.92 ± 1.95 4.76 ± 2.33 <0.001† <0.001†
High blood pressure (Y/N) 825 (87.8) 128 (12.2) 0.011† 0.021†
Diabetes (Y/N) 341 (90.8) 47 (9.2) 0.808 0.874
High cholesterol level (Y/N) 712 (89.3) 105 (10.8) 0.489 0.908
Pulmonar disease (Y/N) 154 (82.6) 35 (17.4) 0.080 0.028†
Cardiac disease (Y/N) 370 (87.6) 67 (12.4) 0.127 0.104
Gastrointestinal diseases (Y/N) 380 (86.4) 72 (13.6) 0.037† 0.121
Neurologic diseases (Y/N) 106 (84.1) 22 (15.9) 0.080 0.256
Allergies (Y/N) 313 (83.0) 57 (17.0) 0.011† 0.015†
Neoplasic disease (Y/N) 128 (91.2) 15 (8.8) 0.732 0.600
Thyroid disease (Y/N) 156 (80.9) 41 (19.1) <0.001† 0.085
Hyperuricemia (Y/N) 193 (89.1) 27 (10.9) 0.655 0.194
Rheumatic disease (Y/N) 685 (84.0) 125 (16.0) <0.001† <0.001†
health resources consumption**
Was hospitalizes since last contact 343 (85.0) 60 (15.1) 0.016† 0.003†
Went to medical appointments in hospitals since last 
contact
7.79 ± 0.36 13.9 ± 4.4 0.150 0.043†
%, weighted percentage; NUTS II, Nomenclatura das Unidades Territoriais, level II; BMI, body mass index (kg/m2); €, euro; HADS-A, Hospital Anxiety and Depression Scale—Anxiety 
subscale; HAQ, Health Assessment Questionnaire (0–3); EQ5D, European Quality of Life questionnaire five dimensions three levels (0–1).
†p-Value ≤ 0.05.
*p-Value was adjusted for age, sex, and region.
**p-Value was adjusted for age, sex, region, and number of non-communicable diseases.
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Table 3 | Sociodemographic, socioeconomic, lifestyle, and health-related characteristics of the Portuguese elderly population with and without depression symptoms.
sociodemographic and socioeconomic 
characteristics
elderly without depression 
symptoms (haDs-D <11)
elderly with depression 
symptoms (haDs-D ≥11)
p-Value adjusted 
p-value
Mean (sD) or n (%) Mean (sD) or n (%)
n = 1,439 (88.23%) n = 241 (11.77%)
age* (years) 73.57 (6.51) 75.74 (7.23) <0.001† 0.001†
Sex* Female 747 (84.47) 161 (15.53) <0.001† <0.001†
Male 692 (91.64) 80 (8.36)
NUTS II* Norte 463 (87.84) 80 (12.16) 0.020† 0.084
Centro 360 (85.41) 67 (14.59)
Lisboa e Vale do Tejo 281 (93.63) 33 (6.37)
Alentejo 89 (87.2) 17 (12.8)
Algarve 50 (86.89) 10 (13.11)
Região Autónoma dos 
Açores
76 (87.77) 11 (12.23)
Região Autónoma da 
Madeira
120 (85.62) 23 (14.38)
Education level* ≤4 years of education 1,046 (65.37) 213 (34.63) <0.001† <0.001†
>4 years of education 373 (76.84) 24 (23.16)
Household income* (€) ≤500 342 (80.53) 100 (19.47) <0.001† 0.007†
501–750 291 (88.06) 41 (11.94)
751–1,000 154 (96.26) 14 (3.74)
>1,000 271 (93.22) 20 (6.78)
Household composition 1 347 (84.05) 82 (15.95) 0.009† 0.161
≥2 1,092 (89.58) 159 (10.42)
anthropometric data*
BMI Underweight 9 (74.53) 2 (24.47) 0.293 0.245
Normal 388 (89.99) 56 (10.01)
Overweight 620 (89.98) 86 (10.02)
Obese 284 (86.98) 53 (13.02)
lifestyle characteristics
Alcohol intake* Never 579 (83.2) 153 (16.8) <0.001† 0.001†
Daily intake 553 (91.7) 58 (8.3)
Occasionally 304 (92.1) 30 (7.9)
Smoke* Never 926 (85.8) 188 (14.2) 0.001† 0.154
Past 434 (93.0) 40 (7.0)
Present 78 (90.2) 13 (9.8)
No regular physical exercise* 807 (85.0) 175 (15.0) <0.001† 0.001
Sleep habits (h) <6 241 (86.1) 47 (13.9) 0.008† 0.048†
≥6 528 (92.1) 59 (7.9)
Quality of life and physical function**
EQ5D (0–1) 0.67 ± 0.02 0.32 ± 0.02 <0.001† <0.001†
HAQ score (0–3) 0.61 ± 0.03 1.38 ± 0.59 <0.001† <0.001†
Number of non-communicable diseases 2.95 ± 1.93 4.36 ± 2.70 <0.001† <0.001†
High blood pressure (Y/N)* 804 (87.2) 149 (12.76) 0.093 0.121
Diabetes (Y/N)* 315 (84.8) 73 (15.2) 0.039† 0.022†
High cholesterol level (Y/N)* 688 (86.0) 129 (14.0) 0.013† 0.056
Pulmonar disease (Y/N)* 150 (82.9) 39 (17.1) 0.023† 0.038†
Cardiac disease (Y/N)* 347 (83.6) 90 (16.5) 0.001† 0.015†
Gastrointestinal diseases (Y/N)* 367 (63.6) 85 (36.4) 0.019† 0.019†
Neurologic diseases (Y/N)* 102 (80.5) 26 (19.5) 0.028† 0.009†
Allergies (Y/N) 312 (87.9) 58 (12.1) 0.074 0.970
Neoplasic disease (Y/N)* 122 (87.3) 21 (12.7) 0.686 0.676
Thyroid disease (Y/N)* 157 (80.6) 40 (19.4) 0.001† 0.061
Hyperuricemia (Y/N)* 181 (83.2) 39 (16.8) 0.010† 0.009†
Rheumatic disease (Y/N)* 649 (82.9) 161 (17.1) <0.001† <0.001†
health resources consumption**
Was hospitalizes since last contact 334 (86.6) 69 (13.4) 0.226 0.043†
Went to medical appointments in hospitals since 
last contact
8.170 ± 0.634 8.961 ± 1.092 0.455 0.376
%, weighted percentage; NUTS II, Nomenclatura das Unidades Territoriais, level II; BMI, body mass index; €, euro; HADS-D, Hospital Anxiety and Depression Scale—Depression 
subscale; HAQ, Health Assessment Questionnaire (0–3); EQ5D, European Quality of Life questionnaire five dimensions three levels (0–1).
†p-Value ≤ 0.05.
*p-Value was adjusted for age, sex, and region.
**p-Value was adjusted for age, sex, region, and number of non-communicable diseases.
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Table 4 | Factors associated with anxiety symptoms in seniors.
anxiety symptoms (yes/no)
Univariable logistic regression Multivariable logistic regression
Or 95% ci p-Value Or 95% ci p-Value
gender
Male Ref.
Female 3.74 2.12–6.62 0.000 2.77 1.53–5.00 0.001
Age (years) 0.98 0.94–1.02 0.371 0.96 0.92–1.00 0.078
nUTs ii
Norte Ref. Ref.
Centro 0.99 0.63–1.57 0.982 0.98 0.60–1.60 0.939
Lisboa 0.92 0.29–3.00 0.897 0.97 0.37–2.54 0.949
Alentejo 0.76 0.37–1.57 0.462 0.79 0.36–1.73 0.553
Algarve 0.65 0.18–2.42 0.525 0.93 0.23–3.78 0.918
Azores 0.66 0.28–1.58 0.356 1.14 0.41–3.18 0.796
Madeira 0.87 0.46–1.66 0.683 0.91 0.48–1.75 0.785
Live alone (Y/N) 1.25 0.75–2.07 0.389
level of education
≤4 years 3.09 1.72–5.54 0.000 2.30 1.22–4.36 0.010
>4 years Ref.
bMi
Underweight Ref.
Normal 0.50 0.10–2.45 0.390
Overweight 0.58 0.11–3.05 0.521
Obese 0.51 0.10–2.52 0.407
alcohol intake
Never Ref.
Daily intake 0.35 0.20–0.62 <0.001
Occasionally 0.65 0.33–1.30 0.224
smoke
Never Ref.
Past 0.82 0.33–2.06 0.680
Present 0.40 0.15–1.06 0.066
No regular physical exercise 0.85 0.48–1.53 0.590
High blood pressure (Y/N) 2.03 1.18–3.50 0.011
Diabetes (Y/N) 0.94 0.56–1.58 0.808
High cholesterol level (Y/N) 1.23 0.69–2.20 0.489
Pulmonar disease (Y/N) 1.64 0.94–2.85 0.080
Cardiac disease (Y/N) 1.50 0.89–2.52 0.127
Gastrointestinal diseases (Y/N) 1.80 1.03–3.13 0.039
Neurologic diseases (Y/N) 1.85 0.93–3.67 0.080
Allergies (Y/N) 2.43 1.23–4.79 0.011 2.02 1.14–3.55 0.015
Neoplasic disease (Y/N) 0.89 0.46–1.72 0.732
Thyroid disease (Y/N) 2.51 1.50–4.20 <0.001
Hyperuricemia (Y/N) 1.13 0.65–1.98 0.655
Rheumatic disease (Y/N) 4.36 2.65–7.16 <0.001 2.92 1.74–4.90 <0.001
HADS-A, Hospital Anxiety and Depression Scale—Anxiety subscale; OR, odds ratio; CI, confidence interval; HAQ, Health Assessment Questionnaire (0–3); EQ5D, European Quality 
of Life questionnaire five dimensions three levels (0–1); BMI, body mass index.
†p-Value ≤ 0.05; GoF (p = 0.287).
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Regarding depression, the estimated prevalence is of 11.8% 
for the Portuguese elderly living in the community, in line with 
the result of 12% for Major Depressive Disorder of the National 
Epidemiologic Study of Mental Health (25). In the Netherlands, 
however, depressive symptoms had a prevalence of 24% for older 
adults—55  years old and older (26), and Castro-Costa et  al. 
exposed a prevalence of depressive symptoms ranging from 33% 
in France, Italy, and Spain, to 18–19%, in Sweden, Denmark, 
Netherlands, Germany, Austria, and Switzerland in adults over 
50 years old (6).
Although the presented figures may suggest that Portuguese 
elderly are less anxious and depressed than other peoples 
DiscUssiOn
This study showed a prevalence of 9.6% of anxiety symptoms 
among the Portuguese with 65 or more years old. This number is 
lower than the ones found in international studies over Australia, 
European, and American countries (24). These authors referred 
prevalence of significant anxiety symptoms between 15 and 52% 
in the elderly living in the community. Almost 10 years ago, an epi-
demiological study in Portugal, whose data were collected between 
2008 and 2009, found the prevalence of generalized anxiety disor-
der in people over 65 years of age at 2.6% and the prevalence of any 
anxiety disorders 20% for the same age group (25).
Table 5 | Factors associated with depression symptoms in seniors.
Depression symptoms (yes/no)
Univariable logistic regression Multivariable logistic regression
Or 95% ci p-Value Or 95% ci p-Value
gender
Male Ref.
Female 2.02 1.42–2.85 <0.001 1.30 0.87–1.94 0.207
Age 1.05 1.02–1.07 <0.001 1.02 1.00–1.05 0.064
nUTs ii
Norte Ref.
Centro 1.23 0.84–1.82 0.289 1.11 0.73–1.70 0.607
Lisboa 0.49 0.29–0.84 0.009 0.51 0.28–0.96 0.037
Alentejo 1.06 0.58–1.94 0.849 1.18 0.64–2.18 0.603
Algarve 1.09 0.49–2.44 0.834 0.25 0.55–2.83 0.590
Azores 1.01 0.49–2.04 0.985 0.56 0.75–3.26 0.237
Madeira 1.21 0.70–2.11 0.492 1.20 0.66–2.18 0.547
Live alone (Y/N) 1.63 1.13–2.35 0.009
level of education (years)
≤4 3.57 2.16–5.92 <0.001 2.40 1.41–4.09 0.001
>4 Ref.
bMi
Underweight Ref.
Normal 0.32 0.06–1.74 0.189
Overweight 0.33 0.06–1.72 0.186
Obese 0.44 0.08–2.30 0.334
alcohol intake
Never Ref.
Daily intake 0.45 0.30–0.66 <0.001 0.54 0.35–0.83 0.005
Occasionally 0.42 0.26–0.70 0.001 0.49 0.29–0.84 0.009
smoke
Never Ref.
Past 0.46 0.30–0.70 <0.001
Present 0.66 0.30–1.44 0.300
No regular physical exercise 2.07 1.44–2.98 <0.001 1.64 1.11–2.42 0.013
High blood pressure (Y/N) 1.35 0.95–1.92 0.094
Diabetes (Y/N) 1.50 1.02–2.21 0.040
High cholesterol level (Y/N) 1.53 1.09–2.14 0.014
Pulmonar disease (Y/N) 1.71 1.07–2.73 0.024
Cardiac disease (Y/N) 1.83 1.27–2.64 0.001
Gastrointestinal diseases (Y/N) 1.56 1.07–2.27 0.020
Neurologic diseases (Y/N) 1.97 1.06–3.63 0.031
Allergies (Y/N) 1.07 0.72–1.57 0.741
Neoplasic disease (Y/N) 1.12 0.65–1.94 0.686
Thyroid disease (Y/N) 2.01 1.31–3.08 0.001
Hyperuricemia (Y/N) 1.74 1.14–2.65 0.011
Rheumatic disease (Y/N) 2.94 2.04–4.23 <0.001 2.12 1.45–3.09 <0.001
HADS-D, Hospital Anxiety and Depression Scale-Depression subscale; OR, odds ratio; CI, confidence interval; HAQ, Health Assessment Questionnaire  
(0–3); EQ5D, European Quality of Life questionnaire five dimensions, three levels (0–1); BMI, body mass index.
Household composition: number of people that live in the house of the participant, including himself/herself.
†p-Value ≤ 0.05; GoF (p = 0.04056).
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in Europe and around the globe, one should be very careful 
when comparing these numbers. There are core discrepancies 
regarding methods of data collection, different instruments of 
assessing depression and anxiety, different nosological entities 
considered (major depression disorder, minor depression dis-
order, generalized anxiety disorder vs symptoms of depression 
and anxiety), and finally different age groups cutoffs (≥50 and 
≥55 vs ≥65).
As Byrne stressed differences in anxiety prevalence rates may 
be due to differences among populations, but also to differences 
in assessment tools and algorithms used for diagnosis such as 
State Trait Anxiety Inventory and Anxiety Disorder Scale (27). 
Some studies use the hierarchical approach to diagnosis, which 
may lead to lower prevalence by excluding individuals with diag-
nostic criteria that also have criteria for diagnosing other higher 
disorders in the hierarchy (3).
Our study demonstrates a close relationship between physical 
function and anxiety and depression showing that seniors with 
lower physical function are more likely to report anxiety and/or 
depression symptoms. Lenze and collaborators performed a liter-
ature review on the association of late life depression and anxiety 
with physical disability. Their findings indicated that depression 
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was a risk factor for disability, but also in the other way, being 
disability a risk factor for depression (28). Brenes and colleagues 
studied the influence of anxiety on the progression of physical 
disability in a community-based observational work, concluding 
that, after adjusting for confounders, anxiety continued to predict 
the development of disability in activities of daily living (29).
In terms of quality of life, our results suggest that seniors with 
anxiety and/or depression are more likely to have reported lower 
levels of quality of life. Sivertsen and colleagues, in their review 
article of 74 studies, concluded the same, demonstrating that 
depressed older people had poor global quality of life than non-
depressed individuals. They added that this association was stable 
over time and independently of how quality of life was measured 
(30). Brenes also considered anxiety in relation to quality of life, 
and her conclusions were similar: anxiety was significantly asso-
ciated with all domains of quality of life, and as severity of anxiety 
symptoms increased, quality of life decreased (31). Having very 
low income was also related to higher depression. This is in line 
with what Valvanne and collaborators defended in their elderly 
population-based study in Finland (32). McCall and colleagues 
findings in USA also corroborated the conclusions that related 
low income to higher scores of depression (33).
To assess determinants for anxiety and depression, a multivari-
able logistic regression, using socioeconomic factors and chronic 
diseases was developed.
The results considering the outcome as a binary variable 
“Anxiety disorders (Yes/No)” showed that being a woman, having 
less than 5 years of education, having a rheumatic disease and 
allergies were factors highly associated to higher scores of the 
anxiety diagnosis in Portuguese elders. Beekman and colleagues 
had already pointed sex and education level out as relevant to 
understand anxiety in their study with LASA cohort data (34).
Although other studies found a significant higher rate of anxi-
ety in women with 55 or more years old (35), this was not found 
in our population.
A global model using multivariable logistic regression was also 
used to capture the framework of factors related to depression in 
Portuguese elderly, level of education, physical inactivity, alcohol 
intake on a daily and occasionally basis, and rheumatic disease 
should be taken into account when considering depression in this 
population.
This is in line with the literature supporting that physical activ-
ity is associated with lower levels of depression (36) Also, several 
studies suggest that lower education is associated with depression 
(37–39).
Regarding alcohol intake, the results found denote that the daily 
or occasional consumption of alcoholic beverages decreases the 
probability of reporting depression among seniors. Although this 
result can be unsettling at first glance, it is important to retain that 
this study assessed consumption frequency, rather than type or 
quantity. In the literature, several studies associate alcohol misuse 
or alcoholism with higher levels of depression (40, 41). That is, 
however, a different matter.
Although literature often expresses a relationship between 
anxiety and/or depression and diabetes (42), pulmonary (43), 
and neoplasic diseases (44), these associations were not con-
firmed in Portuguese senior population. Our study confirms, 
however, conclusions of previous studies on rheumatic diseases 
(11, 45, 46) stressing their important association with both anxi-
ety and depression, as well as the relationship between allergies 
and anxiety, patent in the literature (47).
Interestingly, the female sex is also described in literature as 
an important determinant of depression (46, 48). In our study, 
it was strongly significant even with multivariable analyses with 
single factors separately, such as non-communicable chronic 
diseases, quality of life, or function. But within a global model 
including all significant variables for depression, it loses its 
previous relevance.
Regarding age, Alameda County Study demonstrated a raise 
of depression prevalence with age (49). But multivariable analy-
ses showed that the effect of age was related to physical health 
problems and disability associated with aging. Several studies 
concluded the same way, indicating that although depression 
prevalence increases with age, it should be due to age-related 
factors than age itself (50, 51).
Study limitations should be considered when interpreting 
results. Being cross-sectional, this analysis does not allow to draw 
conclusions about the effects of causality between the variables 
and the chronological order of the events.
Although Breeman defended HADS being used for clinical 
and non-clinical population (52), the use of a specific instrument 
to assess anxiety and depression in this particular age group is 
arguable.
Despite of what has been referred, several strengths related 
to both internal and external validity should be pointed out. 
Data come from large, nationally representative sample of the 
Portuguese elder population followed since 2011, allowing its 
generalization for the age group in our country. It should also be 
noted that data were collected by a team of 10 interviewers who 
were extensively and properly trained, whose proceedings were 
standardized, and regular and rigorously monitored to assess 
quality and reduce bias.
In conclusion, key findings of this study are as follows: (1) 
Portuguese elderly population have prevalence of anxiety and 
depression around 10 and 12%, respectively; (2) anxiety and 
depression are associated to different factors; (3) health-related 
quality of life and physical function play an important role in 
depression and anxiety; and (4) level of education distinguishes 
senior in terms of anxiety and depression.
eThics sTaTeMenT
This study was carried out in accordance with the recom-
mendations of Guidelines for Good Clinical Practice and 
the ethical principles stated in the Declaration of Helsinki, 
National Committee for Data Protection (Comissão Nacional 
de Proteção de Dados) and by the NOVA Medical School Ethics 
Committee, with written informed consent from all subjects. 
All subjects gave written informed consent in accordance with 
the Declaration of Helsinki. The protocol was approved by the 
National Committee for Data Protection (Comissão Nacional 
de Proteção de Dados) and by the NOVA Medical School Ethics 
Committee.
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